Delcath Systems (NASDAQ:DCTH) Getting Somewhat Positive Press Coverage, Study Finds
Press coverage about Delcath Systems (NASDAQ:DCTH) has trended somewhat positive on Wednesday, according to Accern Sentiment Analysis. The research group identifies positive and negative press coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Delcath Systems earned a news sentiment score of 0.14 on Accern’s scale. Accern also assigned media headlines about the medical device company an impact score of 45.7400977652133 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the near term.
These are some of the news stories that may have impacted Accern Sentiment Analysis’s scoring:
- EARNINGS SUMMARY: Details of Delcath Systems Inc. Q2 Earnings Report (rttnews.com)
- Delcath Announces Second Quarter 2017 Financial Results (finance.yahoo.com)
- Watching the Dials on Shares of Delcath Systems Inc (DCTH) – Danville Daily (danvilledaily.com)
- Delcath Systems (DCTH) Stock: Poll Suggests RS Is Imminent (cnafinance.com)
- Delcath Systems Inc (DCTH) Price Holds Above Ichimoku Cloud – Evergreen Caller (evergreencaller.com)
Shares of Delcath Systems (NASDAQ:DCTH) opened at 0.092 on Wednesday. Delcath Systems has a one year low of $0.02 and a one year high of $4.72. The firm’s market cap is $10.90 million. The stock has a 50 day moving average price of $0.15 and a 200 day moving average price of $0.14.
Delcath Systems Company Profile
Delcath Systems, Inc is a late-stage clinical development company with early commercial activity in Europe focused on cancers of the liver. The Company is a specialty pharmaceutical and medical device company developing its product, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS).
Receive News & Ratings for Delcath Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Delcath Systems Inc. and related companies with MarketBeat.com's FREE daily email newsletter.